openPR Logo
Press release

Global Immune-Mediated Inflammatory Diseases Treatment Market Trends, Size, Competitive Analysis and Forecast 2019-2025

06-21-2021 12:15 PM CET | Health & Medicine

Press release from: Orion Market Research

Global Immune-Mediated Inflammatory Diseases Treatment

The global immune-mediated inflammatory disease treatment market is anticipated to grow at a CAGR of over 6% during the forecast period. Immune-mediated inflammatory disease treatment has been improved significantly over the past years due to the development of a series of targeted biological therapies and novel therapies in the market. Currently, quite a lot of research is going on in the field regarding the treatment of immune-mediated disease. In addition, new drugs and treatment options are entering the market, which is fuelling the growth of the global immune-mediated inflammatory disease treatment market. For instance, in August 2019, the US FDA approved upadacitinib (Rinvoq), an oral medication for adults with moderate to severe rheumatoid arthritis that is not being well-controlled by methotrexate.

To Request a Sample of our Report on Global Immune-Mediated Inflammatory Diseases Treatment Market: https://www.omrglobal.com/request-sample/immune-mediated-inflammatory-diseases-treatment-market

However, the late diagnosis of immune-mediated inflammatory disease coupled with challenges during the treatment such as slow or incomplete healing is limiting the growth of the global immune-mediated inflammatory disease treatment market. In addition, the high cost associated with the treatment also restricts the global immune-mediated inflammatory disease treatment market growth. For instance, due to their high costs, considerable differences in the utilization of treatment options exist across the globe. Various European countries are restricting access despite professional society guideline recommendations. Additionally, the adoption of biologic therapies for the treatment by healthcare providers has been particularly poor in many Central and Eastern European countries which are affecting the growth of immune-mediated inflammatory diseases. Moreover, the presence of a small patient base for rare disease coupled with disproportion in the availability of treatments and resources to manage patients, and train experts in developing economies will also limit the growth of the global immune-mediated inflammatory diseases treatment market.

(Get 15% Discount on Buying this Report)
A full Report of Global Immune-Mediated Inflammatory Diseases Treatment Market is Available at: https://www.omrglobal.com/industry-reports/immune-mediated-inflammatory-diseases-treatment-market

Global Immune-Mediated Inflammatory Diseases Treatment Market Segmentation

By Disease Type
• Multiple Sclerosis
• Psoriasis
• Inflammatory Bowel Disease
• Rheumatoid Arthritis
• Others

By Drug Class

• Anti- Inflammatory Biologics
• Non- Steroidal Anti- Inflammatory Drugs
• Corticosteroids

By Treatment Type
• Targeted Biologic Therapies
• Novel Therapies

Regional Analysis

North America
• United States
• Canada

Europe
• UK
• Germany
• Spain
• France
• Italy
• Rest of Europe

Asia-Pacific
• India
• China
• Japan
• Rest of APAC
Rest of The World

Company Profiles
• Abbvie Inc.
• Abivax SA
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• Celgene Corp.
• Daiichi Sankyo Co., Ltd.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences, Inc.
• GlaxoSmithKline PLC
• Innovate Biopharmaceuticals Inc.
• Johnson & Johnson Services Inc.
• LG Chem Ltd.
• Merck & Co., Inc.
• Merck KGaA
• Novartis International AG
• Pharmaxis Ltd.
• Sanofi S.A.
• UCB S.A.
• Ventria Bioscience Inc.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/immune-mediated-inflammatory-diseases-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Immune-Mediated Inflammatory Diseases Treatment Market Trends, Size, Competitive Analysis and Forecast 2019-2025 here

News-ID: 2309735 • Views:

More Releases from Orion Market Research

Connector Market Size Unlocking New Opportunities for Success
Connector Market Size Unlocking New Opportunities for Success
The global Connector Market is estimated to be valued at USD 85.2 billion in 2024 and is projected to reach approximately USD 142.8 billion by 2033, growing at a CAGR of 5.8% during the forecast period from 2025 to 2033. Connector Market Overview: The Connector Market is experiencing strong growth, fueled by rapid advancements in telecommunications, consumer electronics, automotive, and industrial automation. Connectors are critical components for enabling electrical signal transmission and
Natural Solubilizers Market Accelerating Growth with Future Market Size Strategies and Tactics
Natural Solubilizers Market Accelerating Growth with Future Market Size Strategi …
The global Natural Solubilizers Market is estimated to be valued at USD 725.4 million in 2024 and is projected to reach approximately USD 1,264.7 million by 2033, growing at a CAGR of 6.4% during the forecast period from 2025 to 2033. Natural Solubilizers Market Overview: The Natural Solubilizers Market is expanding steadily due to rising consumer preference for clean-label and eco-friendly ingredients across food, cosmetics, and pharmaceutical industries. Natural solubilizers help incorporate
Mobile Phone Chips Market Accelerating Growth with Future Market Size Strategies and Tactics
Mobile Phone Chips Market Accelerating Growth with Future Market Size Strategies …
The global Mobile Phone Chips Market is estimated to be valued at USD 138.5 billion in 2024 and is projected to reach approximately USD 247.6 billion by 2033, growing at a CAGR of 6.8% during the forecast period from 2025 to 2033. Mobile Phone Chips Market Overview: The Mobile Phone Chips Market is witnessing robust growth driven by increasing smartphone adoption, rising demand for high-performance devices, and the expansion of 5G networks
Military Training Aircraft Market Size Opportunities and Challenges for the Future
Military Training Aircraft Market Size Opportunities and Challenges for the Futu …
The global Military Training Aircraft Market is estimated to be valued at USD 9.7 billion in 2024 and is projected to reach approximately USD 14.8 billion by 2033, growing at a CAGR of 4.8% during the forecast period from 2025 to 2033. Military Training Aircraft Market Overview: The Military Training Aircraft Market is growing steadily due to rising defense budgets and the increasing need for advanced pilot training programs worldwide. These aircraft

All 5 Releases


More Releases for Inflammatory

Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant
Inflammatory Marker Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Inflammatory Marker Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Inflammatory Marker market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period. Get the sample
Digital Landscape: Inflammatory Bowel Disease Market
The Digital Landscape Inflammatory Bowel Disease market report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2 …
ReportsWorldwide has announced the addition of a new report title Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2017, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) pipeline landscape. Chronic inflammatory demyelinating polyneuropathy (CIDP) also called as
Research Offers 10-Year Forecast on Inflammatory Diseases Market
A new understanding of inflammatory diseases has changed the drug development landscape for several major diseases that are affecting millions of people in the world. Inflammation describes the primary response of the body that eliminates the cause of injury. Periodically, body’s defense mechanism works inappropriately that leads to inflammation. Drug development has focused on treating each disease symptoms separately. The discovery of drugs to treat inflammatory diseases related with immune